Busca un médico

Vanda A. Lennon, M.D., Ph.D.

Solicite una Consulta

Publicaciones

  1. Peterson E, Rudolph TE, Starr-Moss A, Anderson K, Lennon VA, Shelton GD, Clark LA. Independent CHRNE mutations at serine 503 in English Springer Spaniels and a Smooth Fox Terrier having congenital myasthenic syndrome. Anim Genet. 2024 Aug; 55 (4):702-704 Epub 2024 June 09
    View PubMed
  2. Mangioris G, Halfdanarson TR, Lennon VA, Chang BK, Dubey D, Dyck PJB, Flanagan EP, McKeon A, Mills JR, Pittock SJ, Zekeridou A. Neurological autoimmunity in patients with non-pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profiles. Eur J Neurol. 2024 Jun; 31 (6):e16273 Epub 2024 Mar 11
    View PubMed
  3. Iorio R, Lennon VA. Paraneoplastic autoimmune neurologic disorders associated with thymoma. Handb Clin Neurol. 2024; 200:385-396
    View PubMed
  4. Majed M, Valencia Sanchez C, Bennett JL, Fryer J, Mulligan MD, Redenbaugh V, McKeon A, Mills JR, Wingerchuk DM, Lennon VA, Weinshenker B, Chen JJ, Flanagan EP, Pittock SJ, Kunchok A. Alterations in Aquaporin-4-IgG Serostatus in 986 Patients: A Laboratory-Based Longitudinal Analysis. Ann Neurol. 2023 Oct; 94 (4):727-735 Epub 2023 July 05
    View PubMed
  5. Dubey D, Beecher G, Hammami MB, Knight AM, Liewluck T, Triplett J, Datta A, Dasari S, Zhang Y, Roforth MM, Jerde CR, Murphy SJ, Litchy WJ, Amato A, Lennon VA, McKeon A, Mills JR, Pittock SJ, Milone M. Identification of Caveolae-Associated Protein 4 Autoantibodies as a Biomarker of Immune-Mediated Rippling Muscle Disease in Adults. JAMA Neurol. 2022 Aug 01; 79(8):808-816.
    View PubMed
  6. Guo Y, Lennon VA, Parisi JE, Popescu B, Vasquez C, Pittock SJ, Howe CL, Lucchinetti CF. Spectrum of sublytic astrocytopathy in neuromyelitis optica. Brain. 2022 May 24; 145 (4):1379-1390
    View PubMed
  7. Zekeridou A, Yang B, Lennon VA, Guo Y, Wu L, Lucchinetti CF, McKeon A, Pittock SJ, Flanagan EP. Anti-Neuronal Nuclear Antibody 3 Autoimmunity Targets Dachshund Homolog 1. Ann Neurol. 2022 May; 91 (5):670-675 Epub 2022 Mar 03
    View PubMed
  8. Shah S, Flanagan EP, Paul P, Smith CY, Bryant SC, Devine MF, Lennon VA, McKeon A, Pittock SJ, Dubey D. Population-Based Epidemiology Study of Paraneoplastic Neurologic Syndromes. Neurol Neuroimmunol Neuroinflamm. 2022 Mar; 9 (2) Epub 2021 Dec 22
    View PubMed
  9. Kunchok A, McKeon A, Zekeridou A, Flanagan EP, Dubey D, Lennon VA, Klein CJ, Mills JR, Pittock SJ. Autoimmune/Paraneoplastic Encephalitis Antibody Biomarkers: Frequency, Age, and Sex Associations. Mayo Clin Proc. 2022 Mar; 97 (3):547-559 Epub 2021 Dec 23
    View PubMed
  10. Valencia-Sanchez C, Knight AM, Hammami MB, Guo Y, Mills JR, Kryzer TJ, Piquet AL, Amin A, Heinzelmann M, Lucchinetti CF, Lennon VA, McKeon A, Pittock SJ, Dubey D. Characterisation of TRIM46 autoantibody-associated paraneoplastic neurological syndrome. J Neurol Neurosurg Psychiatry. 2022 Feb; 93 (2):196-200 Epub 2021 Dec 17
    View PubMed
  11. Redenbaugh V, Montalvo M, Sechi E, Buciuc M, Fryer JP, McKeon A, Lennon VA, Mills JR, Weinshenker BG, Wingerchuk DM, Chen JJ, Tariq Bhatti M, Lopez Chiriboga AS, Pittock SJ, Flanagan EP. Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders. Mult Scler J Exp Transl Clin. 2021 Oct; 7 (4):20552173211052656 Epub 2021 Nov 26
    View PubMed
  12. Dubey D, Kryzer T, Guo Y, Clarkson B, Cheville JC, Costello BA, Leibovich BC, Algeciras-Schimnich A, Lucchinnetti C, Hammami MB, Knight AM, Howe C, Lennon VA, McKeon A, Pittock SJ. Leucine Zipper 4 Autoantibody: A Novel Germ Cell Tumor and Paraneoplastic Biomarker. Ann Neurol. 2021 May; 89(5):1001-1010. Epub 2021 Feb 28.
    View PubMed
  13. Wei Y, Chen T, Bosco DB, Xie M, Zheng J, Dheer A, Ying Y, Wu Q, Lennon VA, Wu LJ. The complement C3-C3aR pathway mediates microglia-astrocyte interaction following status epilepticus. Glia. 2021 May; 69 (5):1155-1169 Epub 2020 Dec 14
    View PubMed
  14. Dubey D, Wilson MR, Clarkson B, Giannini C, Gandhi M, Cheville J, Lennon VA, Eggers S, Devine MF, Mandel-Brehm C, Kryzer T, Hinson SR, Khazaie K, Hales C, Kattah J, Pavelko KD, Andrews P, Eaton JE, Jitprapaikulsan J, Mills JR, Flanagan EP, Zekeridou A, Leibovich B, Fryer J, Torre M, Kaufman C, Thoreson JB, Sagen J, Linnoila JJ, DeRisi JL, Howe CL, McKeon A, Pittock SJ. Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis. JAMA Neurol. 2020 Nov 1; 77 (11):1420-1429
    View PubMed
  15. Pittock SJ, Alfugham N, O'Connor K, Hinson S, Kunchok A, Lennon VA, Komorowski L, Probst C, McKeon A. GTPase Regulator Associated with Focal Adhesion Kinase 1 (GRAF1) Immunoglobulin-Associated Ataxia and Neuropathy. Mov Disord Clin Pract. 2020 Nov; 7 (8):904-909 Epub 2020 Sept 14
    View PubMed
  16. Sechi E, Markovic SN, McKeon A, Dubey D, Liewluck T, Lennon VA, Lopez-Chiriboga AS, Klein CJ, Mauermann M, Pittock SJ, Flanagan EP, Zekeridou A. Neurologic autoimmunity and immune checkpoint inhibitors: Autoantibody profiles and outcomes. Neurology. 2020 Oct 27; 95 (17):e2442-e2452 Epub 2020 Aug 13
    View PubMed
  17. Triplett J, Kassardjian CD, Liewluck T, Tahir A, Lennon V, Kopecky S, Milone M. Cardiac and Respiratory Complications of Necrotizing Autoimmune Myopathy. Mayo Clin Proc. 2020 Oct; 95 (10):2144-2149 Epub 2020 Aug 14
    View PubMed
  18. Chen T, Lennon VA, Liu YU, Bosco DB, Li Y, Yi MH, Zhu J, Wei S, Wu LJ. Astrocyte-microglia interaction drives evolving neuromyelitis optica lesion. J Clin Invest. 2020 Aug 3; 130 (8):4025-4038
    View PubMed
  19. Chen JJ, Flanagan EP, Bhatti MT, Jitprapaikulsan J, Dubey D, Lopez Chiriboga ASS, Fryer JP, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Lucchinetti CF, Kunchok A, McClelland CM, Lee MS, Bennett JL, Pelak VS, Van Stavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Lam BL, Moss H, Beres S, Gilbert AL, Shah V, Armstrong G, Heidary G, Cestari DM, Stiebel-Kalish H, Pittock SJ. Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder. Neurology. 2020 Jul 14; 95 (2):e111-e120 Epub 2020 June 17
    View PubMed
  20. Dubey D, Honorat JA, Shelly S, Klein CJ, Komorowski L, Mills JR, Brakopp S, Probst C, Lennon VA, Pittock SJ, McKeon A. Contactin-1 autoimmunity: Serologic, neurologic, and pathologic correlates. Neurol Neuroimmunol Neuroinflamm. 2020 Jul; 7 (4) Epub 2020 May 27
    View PubMed
  21. Cohen DA, Bhatti MT, Pulido JS, Lennon VA, Dubey D, Flanagan EP, Pittock SJ, Klein CJ, Chen JJ. Collapsin Response-Mediator Protein 5-Associated Retinitis, Vitritis, and Optic Disc Edema. Ophthalmology. 2020 Feb; 127 (2):221-229 Epub 2019 Sept 20
    View PubMed
  22. Chen JJ, Pittock SJ, Flanagan EP, Lennon VA, Bhatti MT. Optic neuritis in the era of biomarkers. Surv Ophthalmol. 2020 Jan - Feb; 65 (1):12-17 Epub 2019 Aug 16
    View PubMed
  23. Zhu M, Ma Y, Zekeridou A, Lennon VA. Case Report: Innate Immune System Challenge Unleashes Paraneoplastic Neurological Autoimmunity. Front Neurol. 2020; 11:598894 Epub 2020 Dec 10
    View PubMed
  24. Shelly S, Kryzer TJ, Komorowski L, Miske R, Anderson MD, Flanagan EP, Hinson SR, Lennon VA, Pittock SJ, McKeon A. Neurochondrin neurological autoimmunity. Neurol Neuroimmunol Neuroinflamm. 2019 Nov; 6 (6) Epub 2019 Sept 11
    View PubMed
  25. Honorat JA, Lopez-Chiriboga AS, Kryzer TJ, Komorowski L, Scharf M, Hinson SR, Lennon VA, Pittock SJ, Klein CJ, McKeon A. Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG. Neurology. 2019 Sep 3; 93 (10):e954-e963 Epub 2019 Aug 01
    View PubMed
  26. Zekeridou A, Lennon VA. Neurologic Autoimmunity in the Era of Checkpoint Inhibitor Cancer Immunotherapy. Mayo Clin Proc. 2019 Sep; 94 (9):1865-1878 Epub 2019 July 26
    View PubMed
  27. Zekeridou A, Kryzer T, Guo Y, Hassan A, Lennon V, Lucchinetti CF, Pittock S, McKeon A. Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity. Neurology. 2019 Aug 20; 93 (8):e815-e822 Epub 2019 July 17
    View PubMed
  28. Mandel-Brehm C, Dubey D, Kryzer TJ, O'Donovan BD, Tran B, Vazquez SE, Sample HA, Zorn KC, Khan LM, Bledsoe IO, McKeon A, Pleasure SJ, Lennon VA, DeRisi JL, Wilson MR, Pittock SJ. Kelch-like Protein 11 Antibodies in Seminoma-Associated Paraneoplastic Encephalitis. N Engl J Med. 2019 Jul 4; 381 (1):47-54
    View PubMed
  29. O'Connor K, Waters P, Komorowski L, Zekeridou A, Guo CY, Mgbachi VC, Probst C, Mindorf S, Teegen B, Gelfand JM, Geschwind MD, Lennon V, Pittock SJ, McKeon A. GABAA receptor autoimmunity: A multicenter experience. Neurol Neuroimmunol Neuroinflamm. 2019 May; 6 (3):e552 Epub 2019 Apr 04
    View PubMed
  30. Zekeridou A, Majed M, Heliopoulos I, Lennon VA. Paraneoplastic autoimmunity and small-cell lung cancer: Neurological and serological accompaniments. Thorac Cancer. 2019 Apr; 10 (4):1001-1004 Epub 2019 Feb 27
    View PubMed
  31. Nelson CM, Lennon VA, Lee H, Krug RG 2nd, Kamalova A, Madigan NN, Clark KJ, Windebank AJ, Henley JR. Glucocorticoids Target Ependymal Glia and Inhibit Repair of the Injured Spinal Cord. Front Cell Dev Biol. 2019; 7:56 Epub 2019 Apr 24
    View PubMed
  32. López-Chiriboga AS, Majed M, Fryer J, Dubey D, McKeon A, Flanagan EP, Jitprapaikulsan J, Kothapalli N, Tillema JM, Chen J, Weinshenker B, Wingerchuk D, Sagen J, Gadoth A, Lennon VA, Keegan BM, Lucchinetti C, Pittock SJ. Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders. JAMA Neurol. 2018 Nov 01; 75(11):1355-1363.
    View PubMed
  33. Chen JJ, Flanagan EP, Jitprapaikulsan J, Lopez-Chiriboga AS, Fryer JP, Leavitt JA, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Tobin WO, Keegan BM, Lucchinetti CF, Kantarci OH, McClelland CM, Lee MS, Bennett JL, Pelak VS, Chen Y, VanStavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Brazis PW, Sagen J, Pittock SJ. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome. Am J Ophthalmol. 2018 Nov; 195:8-15 Epub 2018 July 26
    View PubMed
  34. Basal E, Zalewski N, Kryzer TJ, Hinson SR, Guo Y, Dubey D, Benarroch EE, Lucchinetti CF, Pittock SJ, Lennon VA, McKeon A. Paraneoplastic neuronal intermediate filament autoimmunity. Neurology. 2018 Oct 30; 91 (18):e1677-e1689 Epub 2018 Oct 03
    View PubMed
  35. Dubey D, Kothapalli N, McKeon A, Flanagan EP, Lennon VA, Klein CJ, Britton JW, So E, Boeve BF, Tillema JM, Sadjadi R, Pittock SJ. Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunction. J Neuroimmunol. 2018 Oct 15; 323:62-72 Epub 2018 July 25
    View PubMed
  36. Zekeridou A, Griesmann GE, Lennon VA. Mutated cancer autoantigen implicated cause of paraneoplastic myasthenia gravis. Muscle Nerve. 2018 Oct; 58 (4):600-604 Epub 2018 Aug 23
    View PubMed
  37. Jitprapaikulsan J, Chen JJ, Flanagan EP, Tobin WO, Fryer JP, Weinshenker BG, McKeon A, Lennon VA, Leavitt JA, Tillema JM, Lucchinetti C, Keegan BM, Kantarci O, Khanna C, Jenkins SM, Spears GM, Sagan J, Pittock SJ. Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis. Ophthalmology. 2018 Oct; 125 (10):1628-1637 Epub 2018 Apr 30
    View PubMed
  38. Honorat JA, Lopez-Chiriboga AS, Kryzer TJ, Fryer JP, Devine M, Flores A, Lennon VA, Pittock SJ, McKeon A. Autoimmune septin-5 cerebellar ataxia. Neurol Neuroimmunol Neuroinflamm. 2018 Sep; 5 (5):e474 Epub 2018 July 09
    View PubMed
  39. Lopez-Chiriboga AS, Klein C, Zekeridou A, McKeon A, Dubey D, Flanagan EP, Lennon VA, Tillema JM, Wirrell EC, Patterson MC, Gadoth A, Aaen JG, Brenton JN, Bui JD, Moen A, Otten C, Piquet A, Pittock SJ. LGI1 and CASPR2 neurological autoimmunity in children. Ann Neurol. 2018 Sep; 84 (3):473-480
    View PubMed
  40. Dubey D, Hinson SR, Jolliffe EA, Zekeridou A, Flanagan EP, Pittock SJ, Basal E, Drubach DA, Lachance DH, Lennon VA, McKeon A. Autoimmune GFAP astrocytopathy: Prospective evaluation of 90 patients in 1year. J Neuroimmunol. 2018 Aug 15; 321:157-163 Epub 2018 Apr 27
    View PubMed
  41. Gadoth A, Zekeridou A, Klein CJ, Thoreson CJ, Majed M, Dubey D, Flanagan EP, McKeon A, Jenkins SM, Lennon VA, Pittock SJ. Elevated LGI1-IgG CSF index predicts worse neurological outcome. Ann Clin Transl Neurol. 2018 May; 5 (5):646-650 Epub 2018 Apr 02
    View PubMed
  42. Hinson SR, Lopez-Chiriboga AS, Bower JH, Matsumoto JY, Hassan A, Basal E, Lennon VA, Pittock SJ, McKeon A. Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders. Neurol Neuroimmunol Neuroinflamm. 2018 Mar; 5 (2):e438 Epub 2018 Jan 23
    View PubMed
  43. Dubey D, Lennon VA, Gadoth A, Pittock SJ, Flanagan EP, Schmeling JE, McKeon A, Klein CJ. Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases. Neurology. 2018 Jan 9; 90 (2):e103-e110 Epub 2017 Dec 08
    View PubMed
  44. V Willrich MA, Kaleta EJ, Bryant SC, Spears GM, Train LJ, Peterson SE, Lennon VA, Kopecky SL, Baudhuin LM. Genetic variation in statin intolerance and a possible protective role for UGT1A1. Pharmacogenomics. 2018 Jan; 19 (2):83-94 Epub 2017 Dec 06
    View PubMed
  45. Alfugham N, Gadoth A, Lennon VA, Komorowski L, Scharf M, Hinson S, McKeon A, Pittock SJ. ITPR1 autoimmunity: Frequency, neurologic phenotype, and cancer association. Neurol Neuroimmunol Neuroinflamm. 2018 Jan; 5 (1):e418 Epub 2017 Dec 08
    View PubMed
  46. Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, Gadoth A, Smith CY, Bryant SC, Klein CJ, Aksamit AJ, Toledano M, Boeve BF, Tillema JM, Flanagan EP. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol. 2018 Jan; 83 (1):166-177
    View PubMed
  47. Zalewski N, Lennon VA, Pittock SJ, Mckeon A. Calcium channel autoimmunity: Cerebellar ataxia and lambert-eaton syndrome coexisting. Muscle Nerve. 2017 Dec 22 [Epub ahead of print]
    View PubMed
  48. Honorat JA, Komorowski L, Josephs KA, Fechner K, St Louis EK, Hinson SR, Lederer S, Kumar N, Gadoth A, Lennon VA, Pittock SJ, McKeon A. IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients. Neurol Neuroimmunol Neuroinflamm. 2017 Sep; 4 (5):e385 Epub 2017 July 18
    View PubMed
  49. Shimizu F, Schaller KL, Owens GP, Cotleur AC, Kellner D, Takeshita Y, Obermeier B, Kryzer TJ, Sano Y, Kanda T, Lennon VA, Ransohoff RM, Bennett JL. Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica. Sci Transl Med. 2017 Jul 5; 9 (397)
    View PubMed
  50. Dubey D, Singh J, Britton JW, Pittock SJ, Flanagan EP, Lennon VA, Tillema JM, Wirrell E, Shin C, So E, Cascino GD, Wingerchuk DM, Hoerth MT, Shih JJ, Nickels KC, McKeon A. Predictive models in the diagnosis and treatment of autoimmune epilepsy. Epilepsia. 2017 Jul; 58 (7):1181-1189 Epub 2017 May 26
    View PubMed
  51. Gadoth A, Pittock SJ, Dubey D, McKeon A, Britton JW, Schmeling JE, Smith A, Kotsenas AL, Watson RE, Lachance DH, Flanagan EP, Lennon VA, Klein CJ. Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients. Ann Neurol. 2017 Jul; 82 (1):79-92
    View PubMed
  52. Hinson SR, Clift IC, Luo N, Kryzer TJ, Lennon VA. Autoantibody-induced internalization of CNS AQP4 water channel and EAAT2 glutamate transporter requires astrocytic Fc receptor. Proc Natl Acad Sci U S A. 2017 May 23; 114 (21):5491-5496 Epub 2017 May 01
    View PubMed
  53. Lahoria R, Pittock SJ, Gadoth A, Engelstad JK, Lennon VA, Klein CJ. Clinical-pathologic correlations in voltage-gated Kv1 potassium channel complex-subtyped autoimmune painful polyneuropathy. Muscle Nerve. 2017 Apr; 55 (4):520-525 Epub 2017 Feb 13
    View PubMed
  54. Guo Y, Weigand SD, Popescu BF, Lennon VA, Parisi JE, Pittock SJ, Parks NE, Clardy SL, Howe CL, Lucchinetti CF. Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica. Acta Neuropathol. 2017 Apr; 133 (4):597-612 Epub 2017 Feb 09
    View PubMed
  55. Gadoth A, Kryzer TJ, Fryer J, McKeon A, Lennon VA, Pittock SJ. Microtubule-associated protein 1B: Novel paraneoplastic biomarker. Ann Neurol. 2017 Feb; 81: (2)266-277.
    View PubMed
  56. Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, Basal E, Honorat JA, Alfugham NB, Linnoila JJ, Weinshenker BG, Pittock SJ, McKeon A. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients. Ann Neurol. 2017 Feb; 81 (2):298-309
    View PubMed
  57. Takeshita Y, Obermeier B, Cotleur AC, Spampinato SF, Shimizu F, Yamamoto E, Sano Y, Kryzer TJ, Lennon VA, Kanda T, Ransohoff RM. Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro. Neurol Neuroimmunol Neuroinflamm. 2017 Jan; 4 (1):e311 Epub 2016 Dec 19
    View PubMed
  58. Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, Basal E, Honorat JA, Alfugham NB, Linnoila JJ, Weinshenker BG, Pittock SJ, McKeon A. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients Annals of Neurology. 2017; 81: (2)298-309.
  59. Gadoth A, Kryzer TJ, Fryer J, McKeon A, Lennon VA, Pittock SJ. Microtubule-associated protein 1B: Novel paraneoplastic biomarker Annals of Neurology. 2017; 81: (2)266-77.
  60. Honorat JA, Komorowski L, Josephs KA, Fechner K, St Louis EK, Hinson SR, Lederer S, Kumar N, Gadoth A, Lennon VA, Pittock SJ, McKeon A. IgLON5 antibody Neurology: Neuroimmunology and NeuroInflammation. 2017; 4 (5):385
  61. Alfugham N, Roforth M, Komorowski L, Ott A, Meyer W, Probst C, Lennon VA, Pittock SJ, McKeon A. A comparison of tissue-based and recombinant protein-based assays for detecting PCA-Tr/DNER-IgG. Neurol Neuroimmunol Neuroinflamm. 2016 Dec; 3 (6):e294 Epub 2016 Oct 28
    View PubMed
  62. Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock SJ, Aksamit AJ, Lennon VA. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis. JAMA Neurol. 2016 Nov 1; 73 (11):1297-1307
    View PubMed
  63. Zalewski NL, Lennon VA, Lachance DH, Klein CJ, Pittock SJ, Mckeon A. P/Q- and N-type calcium-channel antibodies: Oncological, neurological, and serological accompaniments. Muscle Nerve. 2016 Aug; 54 (2):220-7 Epub 2016 Feb 08
    View PubMed
  64. Zekeridou A, McKeon A, Lennon VA. Frequency of Synaptic Autoantibody Accompaniments and Neurological Manifestations of Thymoma. JAMA Neurol. 2016 Jul 1; 73 (7):853-9
    View PubMed
  65. Apiwattanakul M, Milone M, Pittock SJ, Kryzer TJ, Fryer JP, O'toole O, Mckeon A, Lennon VA. Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy. Muscle Nerve. 2016 Jun; 53 (6):925-32 Epub 2016 Feb 05
    View PubMed
  66. Majed M, Fryer JP, McKeon A, Lennon VA, Pittock SJ. Clinical utility of testing AQP4-IgG in CSF: Guidance for physicians. Neurol Neuroimmunol Neuroinflamm. 2016 Jun; 3 (3):e231 Epub 2016 Apr 20
    View PubMed
  67. Flanagan EP, Cabre P, Weinshenker BG, Sauver JS, St Sauver J, Jacobson DJ, Majed M, Lennon VA, Lucchinetti CF, McKeon A, Matiello M, Kale N, Wingerchuk DM, Mandrekar J, Sagen JA, Fryer JP, Robinson AB, Pittock SJ. Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum. Ann Neurol. 2016 May; 79 (5):775-783 Epub 2016 Apr 04
    View PubMed
  68. Hinson SR, Lennon VA, Pittock SJ. Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders. Handb Clin Neurol. 2016; 133:377-403.
    View PubMed
  69. Rinz CJ, Lennon VA, James F, Thoreson JB, Tsai KL, Starr-Moss AN, Humphries HD, Guo LT, Palmer AC, Clark LA, Shelton GD. A CHRNE frameshift mutation causes congenital myasthenic syndrome in young Jack Russell Terriers. Neuromuscul Disord. 2015 Dec; 25 (12):921-7 Epub 2015 Sept 08
    View PubMed
  70. Kassardjian CD, Lennon VA, Alfugham NB, Mahler M, Milone M. Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy. JAMA Neurol. 2015 Sep; 72 (9):996-1003
    View PubMed
  71. Beversdorf DQ, Roos RP, Hauser WA, Lennon VA, Mehler MF. Animal extremists' threats to neurologic research continue: Neuroreality II. Neurology. 2015 Aug 25; 85 (8):730-4 Epub 2015 July 08
    View PubMed
  72. Zekeridou A, Lennon VA. Aquaporin-4 autoimmunity. Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2 (4):e110 Epub 2015 May 21
    View PubMed
  73. Kruse JL, Lapid MI, Lennon VA, Klein CJ, Toole OO, Pittock SJ, Strand EA, Frye MA, McKeon A. Psychiatric Autoimmunity: N-Methyl-D-Aspartate Receptor IgG and Beyond. Psychosomatics. 2015 May-Jun; 56 (3):227-41 Epub 2015 Feb 04
    View PubMed
  74. Popescu BF, Guo Y, Jentoft ME, Parisi JE, Lennon VA, Pittock SJ, Weinshenker BG, Wingerchuk DM, Giannini C, Metz I, Bruck W, Shuster EA, Carter J, Boyd CD, Clardy SL, Cohen BA, Lucchinetti CF. Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions. Neurology. 2015 Jan 13; 84 (2):148-58 Epub 2014 Dec 10
    View PubMed
  75. Flanagan EP, Weinshenker BG, Krecke KN, Lennon VA, Lucchinetti CF, McKeon A, Wingerchuk DM, Shuster EA, Jiao Y, Horta ES, Pittock SJ. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders. JAMA Neurol. 2015 Jan; 72 (1):81-7
    View PubMed
  76. Tobin WO, Lennon VA, Komorowski L, Probst C, Clardy SL, Aksamit AJ, Appendino JP, Lucchinetti CF, Matsumoto JY, Pittock SJ, Sandroni P, Tippmann-Peikert M, Wirrell EC, McKeon A. DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients. Neurology. 2014 Nov 11; 83 (20):1797-803 Epub 2014 Oct 15
    View PubMed
  77. McKeon A, Lennon VA, Pittock SJ, Kryzer TJ, Murray J. The neurologic significance of celiac disease biomarkers. Neurology. 2014 Nov 11; 83 (20):1789-96 Epub 2014 Sept 26
    View PubMed
  78. Pittock SJ, Lennon VA, Bakshi N, Shen L, McKeon A, Quach H, Briggs FB, Bernstein AL, Schaefer CA, Barcellos LF. Seroprevalence of aquaporin-4-IgG in a northern California population representative cohort of multiple sclerosis. JAMA Neurol. 2014 Nov; 71(11):1433-6.
    View PubMed
  79. Flanagan EP, Saito YA, Lennon VA, McKeon A, Fealey RD, Szarka LA, Murray JA, Foxx-Orenstein AE, Fox JC, Pittock SJ. Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune gastrointestinal dysmotility. Neurogastroenterol Motil. 2014 Sep; 26 (9):1285-97 Epub 2014 July 20
    View PubMed
  80. Brickshawana A, Hinson SR, Romero MF, Lucchinetti CF, Guo Y, Buttmann M, McKeon A, Pittock SJ, Chang MH, Chen AP, Kryzer TJ, Fryer JP, Jenkins SM, Cabre P, Lennon VA. Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study. Lancet Neurol. 2014 Aug; 13 (8):795-806 Epub 2014 July 06
    View PubMed
  81. Guo Y, Lennon VA, Popescu BF, Grouse CK, Topel J, Milone M, Lassmann H, Parisi JE, Pittock SJ, Stefoski D, Balabanov R, Lucchinetti CF. Autoimmune aquaporin-4 myopathy in neuromyelitis optica spectrum. JAMA Neurol. 2014 Aug; 71(8):1025-9.
    View PubMed
  82. Horta ES, Lennon VA, Lachance DH, Jenkins SM, Smith CY, McKeon A, Klein C, Pittock SJ. Neural autoantibody clusters aid diagnosis of cancer. Clin Cancer Res. 2014 Jul 15; 20(14):3862-9. Epub 2014 May 15.
    View PubMed
  83. Fryer JP, Lennon VA, Pittock SJ, Jenkins SM, Fallier-Becker P, Clardy SL, Horta E, Jedynak EA, Lucchinetti CF, Shuster EA, Weinshenker BG, Wingerchuk DM, McKeon A. AQP4 autoantibody assay performance in clinical laboratory service. Neurol Neuroimmunol Neuroinflamm. 2014 Jun; 1 (1):e11 Epub 2014 May 22
    View PubMed
  84. Clardy SL, Lucchinetti CF, Krecke KN, Lennon VA, O'Toole O, Weinshenker BG, Boyd CD, Krieger S, McGraw C, Guo Y, Pittock SJ. Hydrocephalus in neuromyelitis optica. Neurology. 2014 May 20; 82 (20):1841-3 Epub 2014 Apr 23
    View PubMed
  85. Toledano M, Britton JW, McKeon A, Shin C, Lennon VA, Quek AM, So E, Worrell GA, Cascino GD, Klein CJ, Lagerlund TD, Wirrell EC, Nickels KC, Pittock SJ. Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy. Neurology. 2014 May 6; 82 (18):1578-86 Epub 2014 Apr 04
    View PubMed
  86. Figueroa M, Guo Y, Tselis A, Pittock SJ, Lennon VA, Lucchinetti CF, Lisak RP. Paraneoplastic neuromyelitis optica spectrum disorder associated with metastatic carcinoid expressing aquaporin-4. JAMA Neurol. 2014 Apr; 71 (4):495-8
    View PubMed
  87. Philipps G, Alisanski SB, Pranzatelli M, Clardy SL, Lennon VA, McKeon A. Purkinje cell cytoplasmic antibody type 1 (anti-Yo) autoimmunity in a child with Down syndrome. JAMA Neurol. 2014 Mar; 71(3):347-9.
    View PubMed
  88. Gh Popescu BF, Bunyan RF, Guo Y, Parisi JE, Lennon VA, Lucchinetti CF. Evidence of aquaporin involvement in human central pontine myelinolysis Acta Neuropathologica Communications. 2014; 2: (1)40.
  89. Jiao Y, Fryer JP, Lennon VA, McKeon A, Jenkins SM, Smith CY, Quek AM, Weinshenker BG, Wingerchuk DM, Shuster EA, Lucchinetti CF, Pittock SJ. Aquaporin 4 IgG serostatus and outcome in recurrent longitudinally extensive transverse myelitis. JAMA Neurol. 2014 Jan; 71 (1):48-54
    View PubMed
  90. Hole MK, Lennon VA, Cohen ML, Sokol DK. NMDA receptor encephalitis: late treatment also effective. Pediatr Neurol. 2014 Jan; 50(1):115-6. Epub 2013 Oct 08.
    View PubMed
  91. Denys EH, Lennon VA. Asymptomatic lambert-eaton syndrome. Muscle Nerve. 2014; 49(5):764-7.
    View PubMed
  92. Clardy SL, Lennon VA, Dalmau J, Pittock SJ, Jones HR Jr, Renaud DL, Harper CM Jr, Matsumoto JY, McKeon A. Childhood onset of stiff-man syndrome. JAMA Neurol. 2013 Dec; 70 (12):1531-6
    View PubMed
  93. Skjei KL, Lennon VA, Kuntz NL. Muscle specific kinase autoimmune myasthenia gravis in children: a case series. Neuromuscul Disord. 2013 Nov; 23(11):874-82. Epub 2013 Aug 07.
    View PubMed
  94. Jiao Y, Fryer JP, Lennon VA, Jenkins SM, Quek AM, Smith CY, McKeon A, Costanzi C, Iorio R, Weinshenker BG, Wingerchuk DM, Shuster EA, Lucchinetti CF, Pittock SJ. Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology. 2013 Oct 1; 81 (14):1197-204 Epub 2013 Aug 30
    View PubMed
  95. Jeffery OJ, Lennon VA, Pittock SJ, Gregory JK, Britton JW, McKeon A. GABAB receptor autoantibody frequency in service serologic evaluation. Neurology. 2013 Sep 3; 81 (10):882-7 Epub 2013 Aug 07
    View PubMed
  96. Asgari N, Skejoe HP, Lennon VA. Evolution of longitudinally extensive transverse myelitis in an aquaporin-4 IgG-positive patient. Neurology. 2013 Jul 2; 81(1):95-6.
    View PubMed
  97. Pittock SJ, Lennon VA, McKeon A, Mandrekar J, Weinshenker BG, Lucchinetti CF, O'Toole O, Wingerchuk DM. Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Lancet Neurol. 2013 Jun; 12(6):554-62. Epub 2013 Apr 26.
    View PubMed
  98. McKeon A, Lennon VA, LaChance DH, Klein CJ, Pittock SJ. Striational antibodies in a paraneoplastic context. Muscle Nerve. 2013 Apr; 47(4):585-7. Epub 2013 Mar 05.
    View PubMed
  99. O'Toole O, Lennon VA, Ahlskog JE, Matsumoto JY, Pittock SJ, Bower J, Fealey R, Lachance DH, McKeon A. Autoimmune chorea in adults. Neurology. 2013 Mar 19; 80 (12):1133-44 Epub 2013 Feb 20
    View PubMed
  100. Iorio R, Lucchinetti CF, Lennon VA, Farrugia G, Pasricha PJ, Weinshenker BG, Pittock SJ. Intractable nausea and vomiting from autoantibodies against a brain water channel. Clin Gastroenterol Hepatol. 2013 Mar; 11(3):240-5. Epub 2012 Dec 01.
    View PubMed
  101. Klein CJ, Lennon VA, Aston PA, McKeon A, O'Toole O, Quek A, Pittock SJ. Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. JAMA Neurol. 2013 Feb; 70 (2):229-34
    View PubMed
  102. Iorio R, Fryer JP, Hinson SR, Fallier-Becker P, Wolburg H, Pittock SJ, Lennon VA. Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays. J Autoimmun. 2013 Feb; 40:21-7 Epub 2012 Aug 18
    View PubMed
  103. Popescu BF, Bunyan RF, Guo Y, Parisi JE, Lennon VA, Lucchinetti CF. Evidence of aquaporin involvement in human central pontine myelinolysis. Acta Neuropathol Commun. 2013; 1(1):40. Epub 2013 Jul 25
    View PubMed
  104. Meeusen JW, Haselkorn KE, Fryer JP, Kryzer TJ, Gibbons SJ, Xiao Y, Lennon VA. Gastrointestinal hypomotility with loss of enteric nicotinic acetylcholine receptors: active immunization model in mice. Neurogastroenterol Motil. 2013 Jan; 25 (1):84-8.e10 Epub 2012 Oct 17
    View PubMed
  105. McKeon A, Martinez-Hernandez E, Lancaster E, Matsumoto JY, Harvey RJ, McEvoy KM, Pittock SJ, Lennon VA, Dalmau J. Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol. 2013 Jan; 70 (1):44-50
    View PubMed
  106. Meeusen JW, Lennon VA, Klein CJ. Immunotherapy-responsive pain in an abattoir worker with fluctuating potassium channel-complex IgG. Neurology. 2012 Oct 23; 79 (17):1824-5 Epub 2012 Oct 10
    View PubMed
  107. Klein CJ, Lennon VA, Aston PA, McKeon A, Pittock SJ. Chronic pain as a manifestation of potassium channel-complex autoimmunity. Neurology. 2012 Sep 11; 79 (11):1136-44 Epub 2012 Aug 15
    View PubMed
  108. Quek AM, McKeon A, Lennon VA, Mandrekar JN, Iorio R, Jiao Y, Costanzi C, Weinshenker BG, Wingerchuk DM, Lucchinetti CF, Shuster EA, Pittock SJ. Effects of age and sex on aquaporin-4 autoimmunity. Arch Neurol. 2012 Aug; 69 (8):1039-43
    View PubMed
  109. Iorio R, Lennon VA. Neural antigen-specific autoimmune disorders. Immunol Rev. 2012 Jul; 248(1):104-21.
    View PubMed
  110. Horta E, McKeon A, Lennon VA, Benarroch EE. Reversible paraneoplastic tonic pupil with PCA-Tr IgG and Hodgkin lymphoma. Neurology. 2012 May 15; 78(20):1620-2. Epub 2012 May 2.
    View PubMed
  111. Quek AM, Britton JW, McKeon A, So E, Lennon VA, Shin C, Klein C, Watson RE Jr, Kotsenas AL, Lagerlund TD, Cascino GD, Worrell GA, Wirrell EC, Nickels KC, Aksamit AJ, Noe KH, Pittock SJ. Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol. 2012 May; 69 (5):582-93
    View PubMed
  112. Meeusen JW, Klein CJ, Pirko I, Haselkorn KE, Kryzer TJ, Pittock SJ, Lachance DH, Dyck PJ, Lennon VA. Potassium channel complex autoimmunity induced by inhaled brain tissue aerosol. Ann Neurol. 2012 Mar; 71 (3):417-26
    View PubMed
  113. Waters PJ, McKeon A, Leite MI, Rajasekharan S, Lennon VA, Villalobos A, Palace J, Mandrekar JN, Vincent A, Bar-Or A, Pittock SJ. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology. 2012 Feb 28; 78(9):665-71; discussion 669. Epub 2012 Feb 01.
    View PubMed
  114. McKeon A, Robinson MT, McEvoy KM, Matsumoto JY, Lennon VA, Ahlskog JE, Pittock SJ. Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Arch Neurol. 2012 Feb; 69 (2):230-8
    View PubMed
  115. Hinson SR, Romero MF, Popescu BF, Lucchinetti CF, Fryer JP, Wolburg H, Fallier-Becker P, Noell S, Lennon VA. Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proc Natl Acad Sci U S A. 2012 Jan 24; 109 (4):1245-50 Epub 2011 Nov 29
    View PubMed
  116. Caplan JP, Binius T, Lennon VA, Pittock SJ, Rao MS. Pseudopseudoseizures: conditions that may mimic psychogenic non-epileptic seizures. Psychosomatics. 2011 Nov-Dec; 52(6):501-6. Epub 2011 Sep 22.
    View PubMed
  117. Iorio R, Lucchinetti CF, Lennon VA, Costanzi C, Hinson S, Weinshenker BG, Pittock SJ. Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis optica. Neurology. 2011 Oct 25; 77 (17):1644-6 Epub 2011 Oct 12
    View PubMed
  118. McKeon A, Tracy JA, Pittock SJ, Parisi JE, Klein CJ, Lennon VA. Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond. Arch Neurol. 2011 Oct; 68(10):1282-9. Epub 2011 Jun 13.
    View PubMed
  119. Somers KJ, Lennon VA, Rundell JR, Pittock SJ, Drubach DA, Trenerry MR, Lachance DH, Klein CJ, Aston PA, McKeon A. Psychiatric manifestations of voltage-gated potassium-channel complex autoimmunity. J Neuropsychiatry Clin Neurosci. 2011 Fall; 23: (4)425-33.
    View PubMed
  120. Flanagan EP, Lennon VA, Pittock SJ. Autoimmune myelopathies. Continuum.2011 Aug;17:(4):776-99.
  121. Smith JH, Dhamija R, Moseley BD, Sandroni P, Lucchinetti CF, Lennon VA, Kantarci OH. N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresis. Arch Neurol. 2011 Aug; 68(8):1069-72.
    View PubMed
  122. Rudzinski LA, Pittock SJ, McKeon A, Lennon VA, Britton JW. Extratemporal EEG and MRI findings in ANNA-1 (anti-Hu) encephalitis. Epilepsy Res. 2011 Aug; 95(3):255-62. Epub 2011 May 12.
    View PubMed
  123. Magana SM, Keegan BM, Weinshenker BG, Erickson BJ, Pittock SJ, Lennon VA, Rodriguez M, Thomsen K, Weigand S, Mandrekar J, Linbo L, Lucchinetti CF. Beneficial plasma exchange response in central nervous system inflammatory demyelination. Arch Neurol. 2011 Jul; 68 (7):870-8 Epub 2011 Mar 14
    View PubMed
  124. Flanagan EP, McKeon A, Lennon VA, Kearns J, Weinshenker BG, Krecke KN, Matiello M, Keegan BM, Mokri B, Aksamit AJ, Pittock SJ. Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues. Neurology. 2011 Jun 14; 76(24):2089-95.
    View PubMed
  125. Cornelius JR, Pittock SJ, McKeon A, Lennon VA, Aston PA, Josephs KA, Tippmann-Peikert M, Silber MH. Sleep manifestations of voltage-gated potassium channel complex autoimmunity. Arch Neurol. 2011 Jun; 68 (6):733-8
    View PubMed
  126. Pittock SJ, Lennon VA, Dege CL, Talley NJ, Locke GR 3rd. Neural autoantibody evaluation in functional gastrointestinal disorders: a population-based case-control study. Dig Dis Sci. 2011 May; 56 (5):1452-9 Epub 2010 Dec 23
    View PubMed
  127. Popescu BF, Lennon VA, Parisi JE, Howe CL, Weigand SD, Cabrera-Gomez JA, Newell K, Mandler RN, Pittock SJ, Weinshenker BG, Lucchinetti CF. Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology. 2011 Apr 5; 76 (14):1229-37 Epub 2011 Mar 02
    View PubMed
  128. Dhamija R, Renaud DL, Pittock SJ, McKeon A, Lachance DH, Nickels KC, Wirrell EC, Kuntz NL, King MD, Lennon VA. Neuronal voltage-gated potassium channel complex autoimmunity in children. Pediatr Neurol. 2011 Apr; 44 (4):275-81
    View PubMed
  129. McKeon A, Pittock SJ, Lennon VA. CSF complements serum for evaluating paraneoplastic antibodies and NMO-IgG. Neurology. 2011 Mar 22; 76 (12):1108-10
    View PubMed
  130. McKeon A, Ahlskog JE, Britton JW, Lennon VA, Pittock SJ. "Reversible extralimbic paraneoplastic encephalopathies with large abnormalities on magnetic resonance images": Correction. Arch Neurol. 2011 Mar; 68(3):371.
  131. Popescu BF, Parisi JE, Cabrera-Gomez JA, Newell K, Mandler RN, Pittock SJ, Lennon VA, Weinshenker BG, Lucchinetti CF. Absence of cortical demyelination in neuromyelitis optica. Neurology. 2010 Dec 7; 75 (23):2103-9
    View PubMed
  132. Apiwattanakul M, Popescu BF, Matiello M, Weinshenker BG, Lucchinetti CF, Lennon VA, McKeon A, Carpenter AF, Miller GM, Pittock SJ. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol. 2010 Nov; 68 (5):757-61
    View PubMed
  133. Flanagan EP, McKeon A, Lennon VA, Boeve BF, Trenerry MR, Tan KM, Drubach DA, Josephs KA, Britton JW, Mandrekar JN, Lowe V, Parisi JE, Pittock SJ. Autoimmune dementia: clinical course and predictors of immunotherapy response. Mayo Clin Proc. 2010 Oct; 85 (10):881-97
    View PubMed
  134. Pittock SJ, Parisi JE, McKeon A, Roemer SF, Lucchinetti CF, Tan KM, Keegan BM, Hunter SF, Duncan PR, Baehring JM, Matsumoto JY, Lennon VA. Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-Ri). Arch Neurol. 2010 Sep; 67(9):1109-15.
    View PubMed
  135. Hinson SR, McKeon A, Lennon VA. Neurological autoimmunity targeting aquaporin-4. Neuroscience. 2010 Jul 28; 168(4):1009-18. Epub 2009 Aug 20
    View PubMed
  136. Chamberlain JL, Pittock SJ, Oprescu AM, Dege C, Apiwattanakul M, Kryzer TJ, Lennon VA. Peripherin-IgG association with neurologic and endocrine autoimmunity. J Autoimmun. 2010 Jun; 34 (4):469-77 Epub 2010 Jan 12
    View PubMed
  137. Apiwattanakul M, McKeon A, Pittock SJ, Kryzer TJ, Lennon VA. Eliminating false-positive results in serum tests for neuromuscular autoimmunity. Muscle Nerve. 2010 May; 41(5):702-4.
    View PubMed
  138. McKeon A, Apiwattanakul M, Lachance DH, Lennon VA, Mandrekar JN, Boeve BF, Mullan B, Mokri B, Britton JW, Drubach DA, Pittock SJ. Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review. Arch Neurol. 2010 Mar; 67 (3):322-9 Epub 2010 Jan 11
    View PubMed
  139. Breese EH, Dalmau J, Lennon VA, Apiwattanakul M, Sokol DK. Anti-N-methyl-D-aspartate receptor encephalitis: early treatment is beneficial. Pediatr Neurol. 2010 Mar; 42(3):213-4.
    View PubMed
  140. Kraichely RE, Farrugia G, Pittock SJ, Castell DO, Lennon VA. Neural autoantibody profile of primary achalasia. Dig Dis Sci. 2010 Feb; 55 (2):307-11 Epub 2009 June 05
    View PubMed
  141. Lachance DH, Lennon VA, Pittock SJ, Tracy JA, Krecke KN, Amrami KK, Poeschla EM, Orenstein R, Scheithauer BW, Sejvar JJ, Holzbauer S, Devries AS, Dyck PJ. An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive study. Lancet Neurol. 2010 Jan; 9 (1):55-66 Epub 2009 Nov 27
    View PubMed
  142. Petzold A, Pittock S, Lennon V, Maggiore C, Weinshenker BG, Plant GT. Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J Neurol Neurosurg Psychiatry. 2010 Jan; 81(1):109-11.
    View PubMed
  143. Hinson SR, McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Pittock SJ. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells. Arch Neurol. 2009 Sep; 66(9):1164-7.
    View PubMed
  144. McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Hinson SR, Kryzer TJ, Lucchinetti CF, Weinshenker BG, Wingerchuk DM, Shuster EA, Pittock SJ. Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Arch Neurol. 2009 Sep; 66 (9):1134-8
    View PubMed
  145. Magana SM, Pittock SJ, Lennon VA, Keegan BM, Weinshenker BG, Lucchinetti CF. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease. Arch Neurol. 2009 Aug; 66 (8):964-6
    View PubMed
  146. McKeon A, Lennon VA, Lachance DH, Fealey RD, Pittock SJ. Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments. Arch Neurol. 2009 Jun; 66 (6):735-41
    View PubMed
  147. Magana SM, Matiello M, Pittock SJ, McKeon A, Lennon VA, Rabinstein AA, Shuster E, Kantarci OH, Lucchinetti CF, Weinshenker BG. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology. 2009 Feb 24; 72(8):712-7.
    View PubMed
  148. McKeon A, Lennon VA, Jacob A, Matiello M, Lucchinetti CF, Kale N, Chan KH, Weinshenker BG, Apiwattinakul M, Wingerchuk DM, Pittock SJ. Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve. 2009 Jan; 39(1):87-90.
    View PubMed
  149. Hinson SR, Roemer SF, Lucchinetti CF, Fryer JP, Kryzer TJ, Chamberlain JL, Howe CL, Pittock SJ, Lennon VA. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med. 2008 Oct 27; 205 (11):2473-81 Epub 2008 Oct 06
    View PubMed
  150. Geschwind MD, Tan KM, Lennon VA, Barajas RF Jr, Haman A, Klein CJ, Josephson SA, Pittock SJ. Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease. Arch Neurol. 2008 Oct; 65 (10):1341-6
    View PubMed
  151. Ruff RL, Lennon VA. How myasthenia gravis alters the safety factor for neuromuscular transmission. J Neuroimmunol. 2008 Sep 15; 201-202:13-20. Epub 2008 Jul 15.
    View PubMed
  152. Dhamija R, Tan KM, Pittock SJ, Foxx-Orenstein A, Benarroch E, Lennon VA. Serologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotility. Clin Gastroenterol Hepatol. 2008 Sep; 6 (9):988-92 Epub 2008 July 02
    View PubMed
  153. Pulido J, Pulido J, Cross SA, Lennon VA, Pulido J, Swanson D, Muench M, Swanson D, Lachance DH. Bilateral autoimmune optic neuritis and vitreitis related to CRMP-5-IgG: intravitreal triamcinolone acetonide therapy of four eyes. Eye (Lond). 2008 Sep; 22 (9):1191-3 Epub 2007 Aug 24
    View PubMed
  154. McKeon A, Lennon VA, Lotze T, Tenenbaum S, Ness JM, Rensel M, Kuntz NL, Fryer JP, Homburger H, Hunter J, Weinshenker BG, Krecke K, Lucchinetti CF, Pittock SJ. CNS aquaporin-4 autoimmunity in children. Neurology. 2008 Jul 8; 71 (2):93-100 Epub 2008 May 28
    View PubMed
  155. Matiello M, Lennon VA, Jacob A, Pittock SJ, Lucchinetti CF, Wingerchuk DM, Weinshenker BG. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology. 2008 Jun 3; 70(23):2197-200. Epub 2008 Apr 23.
    View PubMed
  156. Tan KM, Lennon VA, Klein CJ, Boeve BF, Pittock SJ. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology. 2008 May 13; 70 (20):1883-90
    View PubMed
  157. Pittock SJ, Lennon VA. Aquaporin-4 autoantibodies in a paraneoplastic context. Arch Neurol. 2008 May; 65 (5):629-32
    View PubMed
  158. Keegan BM, Pittock SJ, Lennon VA. Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G. Ann Neurol. 2008 Apr; 63 (4):531-4
    View PubMed
  159. Banwell B, Tenembaum S, Lennon VA, Ursell E, Kennedy J, Bar-Or A, Weinshenker BG, Lucchinetti CF, Pittock SJ. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology. 2008 Jan 29; 70(5):344-52. Epub 2007 Dec 19
    View PubMed
  160. Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zephir H, Moder K, Weinshenker BG. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol. 2008 Jan; 65 (1):78-83
    View PubMed
  161. Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, Lennon VA. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology. 2007 Dec 11; 69 (24):2221-31 Epub 2007 Oct 10
    View PubMed
  162. Chan KH, Lachance DH, Harper CM, Lennon VA. Frequency of seronegativity in adult-acquired generalized myasthenia gravis. Muscle Nerve. 2007 Nov; 36(5):651-8.
    View PubMed
  163. McKeon A, Pittock SJ, Glass GA, Josephs KA, Bower JH, Lennon VA, Ahlskog JE. Whole-body tremulousness: isolated generalized polymyoclonus. Arch Neurol. 2007 Sep; 64 (9):1318-22
    View PubMed
  164. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol. 2007 Sep; 6 (9):805-15
    View PubMed
  165. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007 May; 130 (Pt 5):1194-205 Epub 2007 Feb 04
    View PubMed
  166. Thieben MJ, Sandroni P, Sletten DM, Benrud-Larson LM, Fealey RD, Vernino S, Lennon VA, Shen WK, Low PA. Postural orthostatic tachycardia syndrome: the Mayo clinic experience. Mayo Clin Proc. 2007 Mar; 82(3):308-13.
    View PubMed
  167. Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA, Weinshenker BG. A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology. 2007 Feb 20; 68 (8):603-5
    View PubMed
  168. Pasha SF, Lunsford TN, Lennon VA. Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine. Gastroenterology. 2006 Nov; 131: (5)1592-6.
    View PubMed
  169. Pittock SJ, Yoshikawa H, Ahlskog JE, Tisch SH, Benarroch EE, Kryzer TJ, Lennon VA. Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc. 2006 Sep; 81 (9):1207-14
    View PubMed
  170. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006 Jul; 63 (7):964-8
    View PubMed
  171. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 May 23; 66 (10):1485-9
    View PubMed
  172. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006 Mar; 63 (3):390-6
    View PubMed
  173. Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, Lennon VA. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006 Mar; 59 (3):566-9
    View PubMed
  174. Castillo P, Woodruff B, Caselli R, Vernino S, Lucchinetti C, Swanson J, Noseworthy J, Aksamit A, Carter J, Sirven J, Hunder G, Fatourechi V, Mokri B, Drubach D, Pittock S, Lennon V, Boeve B. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 2006 Feb; 63 (2):197-202
    View PubMed
  175. Weinshenker BG, Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA. NMO-IgG: a specific biomarker for neuromyelitis optica. Dis Markers. 2006; 22 (4):197-206
    View PubMed
  176. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005 Aug 15; 202 (4):473-7 Epub 2005 Aug 08
    View PubMed
  177. Pittock SJ, Lucchinetti CF, Parisi JE, Benarroch EE, Mokri B, Stephan CL, Kim KK, Kilimann MW, Lennon VA. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol. 2005 Jul; 58(1):96-107.
    View PubMed
  178. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004 Dec 11-17; 364 (9451):2106-12
    View PubMed
  179. Matsuyama Z, Yanagisawa NK, Aoki Y, Black JL, Lennon VA, Mori Y, Imoto K, Inuzuka T. Polyglutamine repeats of spinocerebellar ataxia 6 impair the cell-death-preventing effect of Ca(v)2.1 Ca2+ channel-loss-of-function cellular model of SCA6. Neurobiol Dis. 2004 Nov; 17(2):198-204.
    View PubMed
  180. Vernino S, Lennon VA. Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res. 2004 Nov 1; 10(21):7270-5.
    View PubMed
  181. Pittock SJ, Kryzer TJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol. 2004 Nov; 56 (5):715-9
    View PubMed
  182. Vernino S, Ermilov LG, Sha L, Szurszewski JH, Low PA, Lennon VA. Passive transfer of autoimmune autonomic neuropathy to mice. J Neurosci. 2004 Aug 11; 24 (32):7037-42
    View PubMed
  183. Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Keegan M, Vernino S. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology. 2004 Apr 13; 62 (7):1177-82
    View PubMed
  184. Sandroni P, Vernino S, Klein CM, Lennon VA, Benrud-Larson L, Sletten D, Low PA. Idiopathic autonomic neuropathy: comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody. Arch Neurol. 2004 Jan; 61(1):44-8.
    View PubMed
  185. Rakocevic G, Barohn R, McVey AL, Damjanov I, Morte PD, Vernino S, Lennon V. Myasthenia gravis, thymoma, and intestinal pseudo-obstruction: a case report and review. J Clin Neuromuscul Dis. 2003 Dec; 5 (2):93-5
    View PubMed
  186. Samii A, Dahlen DD, Spence AM, Maronian NC, Kraus EE, Lennon VA. Paraneoplastic movement disorder in a patient with non-Hodgkin's lymphoma and CRMP-5 autoantibody. Mov Disord. 2003 Dec; 18(12):1556-8.
    View PubMed
  187. Burns TM, Jones HR, Phillips LH, Bugawan TL, Erlich HA, Lennon VA. Clinically disparate stiff-person syndrome with GAD65 autoantibody in a father and daughter. Neurology. 2003 Nov 11; 61(9):1291-3.
    View PubMed
  188. Lawn ND, Westmoreland BF, Kiely MJ, Lennon VA, Vernino S. Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc. 2003 Nov; 78 (11):1363-8
    View PubMed
  189. Joshi DD, Anderson PM, Matsumoto J, Moir C, Shives T, Unni K, Lennon VA. Metastatic chondroblastoma with elevated creatine kinase and paraneoplastic neurologic autoimmunity. J Pediatr Hematol Oncol. 2003 Nov; 25 (11):900-4
    View PubMed
  190. Vernino S, Low PA, Lennon VA. Experimental autoimmune autonomic neuropathy. J Neurophysiol. 2003 Sep; 90(3):2053-9.
    View PubMed
  191. Vernino S, Lennon VA. Muscle and neuronal autoantibody markers of thymoma: neurological correlations. Ann N Y Acad Sci. 2003 Sep; 998:359-61
    View PubMed
  192. Vernino S, Lennon VA. Neuronal ganglionic acetylcholine receptor autoimmunity. Ann N Y Acad Sci. 2003 Sep; 998:211-4
    View PubMed
  193. Cross SA, Salomao DR, Parisi JE, Kryzer TJ, Bradley EA, Mines JA, Lam BL, Lennon VA. Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Ann Neurol. 2003 Jul; 54 (1):38-50
    View PubMed
  194. Klein CM, Vernino S, Lennon VA, Sandroni P, Fealey RD, Benrud-Larson L, Sletten D, Low PA. The spectrum of autoimmune autonomic neuropathies. Ann Neurol. 2003 Jun; 53(6):752-8.
    View PubMed
  195. Ermilov LG, Miller SM, Schmalz PF, Hanani M, Lennon VA, Szurszewski JH. Morphological characteristics and immunohistochemical detection of nicotinic acetylcholine receptors on intestinofugal afferent neurones in guinea-pig colon. Neurogastroenterol Motil. 2003 Jun; 15 (3):289-98
    View PubMed
  196. Pittock SJ, Lucchinetti CF, Lennon VA. Anti-neuronal nuclear autoantibody type 2: Paraneoplastic accompaniments. Ann Neurol 2003 May; 53(5):580-7.
    View PubMed
  197. Lennon VA, Ermilov LG, Szurszewski JH, Vernino S. Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J Clin Invest. 2003 Mar; 111 (6):907-13
    View PubMed
  198. Vernino S, Lennon VA. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Muscle & Nerve. 2002 Nov; 26(5):702-7.
    View PubMed
  199. Vernino S, Eggenberger ER, Rogers LR, Lennon VA. Paraneoplastic neurological autoimmunity associated with ANNA-1 autoantibody and thymoma. Neurology. 2002 Sep 24; 59 (6):929-32
    View PubMed
  200. Yoshikawa H, Lennon VA. ACh receptor protein drives primary and memory autoantibody responses in chimeric human-SCID mice. Clin Immunol. 2002 Aug; 104 (2):128-37
    View PubMed
  201. Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, Lennon VA, Celis E, Chen L. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med. 2002 Aug; 8 (8):793-800 Epub 2002 June 24
    View PubMed
  202. Pardi DS, Miller SM, Miller DL, Burgart LJ, Szurszewski JH, Lennon VA, Farrugia G. Paraneoplastic dysmotility: loss of interstitial cells of Cajal. Am J Gastroenterol. 2002 Jul; 97(7):1828-33.
    View PubMed
  203. Vernino S, Tuite P, Adler CH, Meschia JF, Boeve BF, Boasberg P, Parisi JE, Lennon VA. Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol. 2002 May; 51(5):625-30.
    View PubMed
  204. Manley HA, Lennon VA. Endoplasmic reticulum membrane-sorting protein of lymphocytes (BAP31) is highly expressed in neurons and discrete endocrine cells. J Histochem Cytochem. 2001 Oct; 49: (10)1235-43.
    View PubMed
  205. Chan KH, Vernino S, Lennon VA. ANNA-3 anti-neuronal nuclear antibody: marker of lung cancer-related autoimmunity. Ann Neurol. 2001 Sep; 50 (3):301-11
    View PubMed
  206. Thambisetty MR, Scherzer CR, Yu Z, Lennon VA, Newman NJ. Paraneoplastic optic neuropathy and cerebellar ataxia with small cell carcinoma of the lung. J Neuroophthalmol. 2001 Sep; 21(3):164-7.
    View PubMed
  207. Vernino S, Cheshire WP, Lennon VA. Myasthenia gravis with autoimmune autonomic neuropathy. Auton Neurosci. 2001 May 14; 88 (3):187-92
    View PubMed
  208. Fletcher CF, Tottene A, Lennon VA, Wilson SM, Dubel SJ, Paylor R, Hosford DA, Tessarollo L, McEnery MW, Pietrobon D, Copeland NG, Jenkins NA. Dystonia and cerebellar atrophy in Cacna1a null mice lacking P/Q calcium channel activity. FASEB J. 2001 May; 15(7):1288-90.
    View PubMed
  209. Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol. 2001 Feb; 49(2):146-54.
    View PubMed
  210. Lee HR, Lennon VA, Camilleri M, Prather CM. Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics. Am J Gastroenterol. 2001 Feb; 96(2):373-9.
    View PubMed
  211. Rickman OB, Parisi JE, Yu Z, Lennon VA, Vernino S. Fulminant autoimmune cortical encephalitis associated with thymoma treated with plasma exchange. Mayo Clin Proc. 2000 Dec; 75(12):1321-6.
    View PubMed
  212. Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med. 2000 Sep 21; 343 (12):847-55
    View PubMed
  213. Vernino S, Lennon VA. New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity. Ann Neurol. 2000 Mar; 47(3):297-305.
    View PubMed
  214. King PH, Redden D, Palmgren JS, Nabors LB, Lennon VA. Hu antigen specificities of ANNA-1 autoantibodies in paraneoplastic neurological disease. J Autoimmun. 1999 Dec; 13(4):435-443.
    View PubMed
  215. Black JL 3rd, Nelson TR, Snow K, Lennon VA. Immunogenicity of P/Q-type calcium channel in small cell lung cancer: investigation of alpha1 subunit polyglutamine expansion. Tissue Antigens. 1999 Dec; 54 (6):592-6
    View PubMed
  216. Vernino S, Auger RG, Emslie-Smith AM, Harper CM, Lennon VA. Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability. Neurology. 1999 Oct 12; 53 (6):1233-9
    View PubMed
  217. Tang H, Miller SM, Ermilov LG, Lennon VA, Brimijoin S, Brimijoin S. Complement-mediated lesion of sympathetic ganglia in vitro with acetylcholinesterase antibodies. J Neuroimmunol. 1999 Jun 1; 97 (1-2):86-93
    View PubMed
  218. Galanis E, Frytak S, Rowland KM Jr, Sloan JA, Lennon VA. Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum-associated neuropathy. Cancer Immunol Immunother. 1999 May-Jun; 48 (2-3):85-90
    View PubMed
  219. Black JL 3rd, Lennon VA. Identification and cloning of putative human neuronal voltage-gated calcium channel gamma-2 and gamma-3 subunits: neurologic implications. Mayo Clin Proc. 1999 Apr; 74 (4):357-61
    View PubMed
  220. Yu Z, Lennon VA. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N Engl J Med. 1999 Jan 21; 340 (3):227-8
    View PubMed
  221. Walikonis JE, Lennon VA. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus. Mayo Clin Proc. 1998 Dec; 73(12):1161-6.
    View PubMed
  222. Lindstrom J, Seybold ME, Lennon VA, Whittingham S, Duane DD. Antibody to acetylcholine receptor in myasthenia gravis: Prevalence, clinical correlates, and diagnostic value. Neurology. 1998 Oct; 51:993.
    View PubMed
  223. Khwaja S, Sripathi N, Ahmad BK, Lennon VA. Paraneoplastic motor neuron disease with type 1 Purkinje cell antibodies. Muscle Nerve. 1998 Jul; 21(7):943-5.
    View PubMed
  224. Vernino S, Adamski J, Kryzer TJ, Fealey RD, Lennon VA. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology. 1998 Jun; 50 (6):1806-13
    View PubMed
  225. Black JL, Griesmann GE, Erickson J, Kryzer TJ, Lamke GT, Lennon VA. Lambert-Eaton myasthenic syndrome. Antigenicity of recombinant human P/Q-type calcium channel alpha 1 subunit putative ion pore region (domain IV, S5-S6). Ann N Y Acad Sci. 1998 May 13; 841:691-5
    View PubMed
  226. Sciamanna MA, Griesmann GE, Lennon VA. A small cell lung carcinoma line and subclone expressing nicotinic acetylcholine receptors of muscle and neuronal types. Ann N Y Acad Sci. 1998 May 13; 841:655-8
    View PubMed
  227. Ruff RL, Lennon VA. End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis. Ann Neurol. 1998 Mar; 43(3):370-9.
    View PubMed
  228. Lucchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology. 1998 Mar; 50 (3):652-7
    View PubMed
  229. O'Suilleabhain P, Low PA, Lennon VA. Autonomic dysfunction in the Lambert-Eaton myasthenic syndrome: serologic and clinical correlates. Neurology. 1998 Jan; 50 (1):88-93
    View PubMed
  230. Sciamanna MA, Griesmann GE, Williams CL, Lennon VA. Nicotinic acetylcholine receptors of muscle and neuronal (alpha7) types coexpressed in a small cell lung carcinoma. J Neurochem. 1997 Dec; 69 (6):2302-11
    View PubMed
  231. Yoshikawa H, Lambert EH, Walser-Kuntz DR, Yasukawa Y, McCormick DJ, Lennon VA. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis. J Immunol. 1997 Aug 1; 159(3):1570-7.
    View PubMed
  232. Yoshikawa H, Lennon VA. Acetylcholine receptor autoantibody secretion by thymocytes: relationship to myasthenia gravis. Neurology. 1997 Aug; 49 (2):562-7
    View PubMed
  233. Ahlskog JE, Petersen RC, Waring SC, Esteban-Santillan C, Craig UK, Maraganore DM, Lennon VA, Kurland LT. Guamanian neurodegenerative disease: are diabetes mellitus and altered humoral immunity clues to pathogenesis? Neurology. 1997 May; 48 (5):1356-62
    View PubMed
  234. Lennon VA. Serologic profile of myasthenia gravis and distinction from the Lambert-Eaton myasthenic syndrome. Neurology. 1997; 48(4 Suppl 5):S23-S27.
  235. Meriney SD, Hulsizer SC, Lennon VA, Grinnell AD. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma. Ann Neurol. 1996 Nov; 40(5):739-49.
    View PubMed
  236. Robinson IM, Yamada M, Carrion-Vazquez M, Lennon VA, Fernandez JM. Specialized release zones in chromaffin cells examined with pulsed-laser imaging. Cell Calcium. 1996 Aug; 20 (2):181-201
    View PubMed
  237. Liu H, De Waard M, Scott VE, Gurnett CA, Lennon VA, Campbell KP. Identification of three subunits of the high affinity omega-conotoxin MVIIC-sensitive Ca2+ channel. J Biol Chem. 1996 Jun 7; 271(23):13804-10.
    View PubMed
  238. Scott VE, De Waard M, Liu H, Gurnett CA, Venzke DP, Lennon VA, Campbell KP. Beta subunit heterogeneity in N-type Ca2+ channels. J Biol Chem. 1996 Feb 9; 271(6):3207-12.
    View PubMed
  239. Rodriguez M, Rodriguez M, Miller DJ, Lennon VA. Immunoglobulins reactive with myelin basic protein promote CNS remyelination. Neurology. 1996 Feb; 46 (2):538-45
    View PubMed
  240. Fairman CL, Clagett-Dame M, Lennon VA, Epstein ML. Appearance of neurons in the developing chick gut. Dev Dyn. 1995 Oct; 204(2):192-201.
    View PubMed
  241. Lennon VA, Kryzer TJ, Griesmann GE, O'Suilleabhain PE, Windebank AJ, Woppmann A, Miljanich GP, Lambert EH. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med. 1995 Jun 1; 332 (22):1467-74
    View PubMed
  242. Lennon VA. Paraneoplastic autoantibodies: the case for a descriptive generic nomenclature. Neurology. 1994 Dec; 44 (12):2236-40
    View PubMed
  243. Kim J, Namchuk M, Bugawan T, Fu Q, Jaffe M, Shi YG, Aanstoot HJ, Turck CW, Erlich H, Lennon VA, Baekkeskov S. Higher autoantibody levels and recognition of a linear nh2-terminal epitope in the autoantigen gad(65), distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J Exp Med. 1994 Aug 1; 180:595-606.
    View PubMed
  244. Cai Q, Hodgson SF, Kao PC, Lennon VA, Klee GG, Zinsmiester AR, Kumar R. Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. N Engl J Med. 1994 Jun 9; 330: (23)1645-9.
    View PubMed
  245. Lennon VA. Cross-talk between nervous and immune systems in response to injury. Prog Brain Res. 1994; 103:289-92
    View PubMed
  246. Chu G, Wilson PC, Carter CD, Lennon VA, Roberts-Thomson IC. Intestinal pseudo-obstruction, type 1 anti-neuronal nuclear antibodies and small-cell carcinoma of the lung. Journal of Gastroenterology & Hepatology. 1993 Nov-Dec; 8(6):604-6.
    View PubMed
  247. Chalk CH, Lennon VA, Stevens JC, Windebank AJ. Seronegativity for type 1 antineuronal nuclear antibodies ('anti-Hu') in subacute sensory neuronopathy patients without cancer. Neurology. 1993 Nov; 43 (11):2209-11
    View PubMed
  248. Parkman HP, Stapelfeldt WH, Williams CL, Lennon VA, Szurszewski JH. Enteric GABA-containing nerves projecting to the guinea-pig inferior mesenteric ganglion modulate acetylcholine release. J Physiol. 1993 Nov; 471:191-207
    View PubMed
  249. Brimijoin S, Moser V, Brimijoin S, Hammond P, Oka N, Lennon VA. Death of intermediolateral spinal cord neurons follows selective, complement-mediated destruction of peripheral preganglionic sympathetic terminals by acetylcholinesterase antibodies. Neuroscience. 1993 May; 54 (1):201-23
    View PubMed
  250. McCormick DJ, Liebenow JA, Griesmann GE, Lennon VA. Nine residues influence the binding of alpha-bungarotoxin in alpha-subunit region 185-200 of human muscle acetylcholine receptor. J Neurochem. 1993 May; 60 (5):1906-14
    View PubMed
  251. Sano M, Lennon VA. Enzyme immunoassay of anti-human acetylcholine receptor autoantibodies in patients with myasthenia gravis reveals correlation with striational autoantibodies. Neurology. 1993 Mar; 43 (3 Pt 1):573-8
    View PubMed
  252. Oguro-Okano M, Griesmann GE, Wieben ED, Slaymaker SJ, Snutch TP, Lennon VA. Molecular diversity of neuronal-type calcium channels identified in small cell lung carcinoma. Mayo Clin Proc. 1992 Dec; 67 (12):1150-9
    View PubMed
  253. Victor KD, Pascual V, Williams CL, Lennon VA, Capra JD. Human monoclonal striational autoantibodies isolated from thymic B lymphocytes of patients with myasthenia gravis use VH and VL gene segments associated with the autoimmune repertoire. Eur J Immunol. 1992 Sep; 22(9):2231-6.
    View PubMed
  254. Williams CL, Hay JE, Huiatt TW, Lennon VA. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin. Lab Invest. 1992 Mar; 66(3):331-6.
    View PubMed
  255. Sano M, Lambert EH, McCormick DJ, Lennon VA. Muscle acetylcholine receptors complexed with autologous IgG reflect seropositivity but not necessarily in vivo binding. Neurology. 1992 Jan; 42 (1):218-22
    View PubMed
  256. Small S, Ali HH, Lennon VA, Brown RH Jr, Carr DB, de Armendi A. Anesthesia for an unsuspected Lambert-Eaton myasthenic syndrome with autoantibodies and occult small cell lung carcinoma. Anesthesiology. 1992 Jan; 76(1):142-5.
    View PubMed
  257. Kiers L, Altermatt HJ, Lennon VA. Paraneoplastic anti-neuronal nuclear IgG autoantibodies (type I) localize antigen in small cell lung carcinoma. Mayo Clin Proc. 1991 Dec; 66 (12):1209-16
    View PubMed
  258. Glass JB, Sher PK, Lennon VA, Regelmann WE. The association of pauciarticular juvenile arthritis and myasthenia gravis. Am J Dis Child. 1991 Oct; 145(10):1176-80.
    View PubMed
  259. Altermatt HJ, Rodriguez M, Scheithauer BW, Lennon VA. Paraneoplastic anti-Purkinje and type I anti-neuronal nuclear autoantibodies bind selectively to central, peripheral, and autonomic nervous system cells. Lab Invest. 1991 Oct; 65(4):412-20.
    View PubMed
  260. Sano M, McCormick DJ, Talib S, Griesmann GE, Lennon VA. Identification of three extended antibody-binding segments in recombinant human muscle acetylcholine receptor alpha subunit extracellular domain 1-210. Int Immunol. 1991 Oct; 3 (10):983-9
    View PubMed
  261. Williams CL, Lennon VA. Activation of muscarinic acetylcholine receptors inhibits cell cycle progression of small cell lung carcinoma. Cell Regul. 1991 May; 2 (5):373-81
    View PubMed
  262. Griesmann GE, McCormick DJ, Lennon VA. An avidin-biotin-peroxidase assay to detect synthetic peptides bound to polystyrene plates. J Immunol Methods. 1991 Apr 8; 138 (1):25-9
    View PubMed
  263. Lennon VA, Lambert EH, Leiby KR, Okarma TB, Talib S. Recombinant human acetylcholine receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravis. J Immunol. 1991 Apr 1; 146(7):2245-8.
    View PubMed
  264. Lennon VA, Sas DF, Busk MF, Scheithauer B, Malagelada JR, Camilleri M, Miller LJ. Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology. 1991 Jan; 100 (1):137-42
    View PubMed
  265. Brimijoin S, Brimijoin S, Lennon VA. Selective destruction of preganglionic sympathetic nerves by antibodies to acetylcholinesterase. J Neural Transm Suppl. 1991; 34:139-45
    View PubMed
  266. Williams CL, Lennon VA. Striational autoantibodies: paraneoplastic antibodies associated with thymoma and myasthenia gravis. Clinical Immunology Newsletter. 1991; 11:161-170.
  267. Krco CJ, David CS, Lennon VA. Mouse T lymphocyte response to acetylcholine receptor determined by T cell antigen receptor v beta gene products recognizing Mlsa. J Immunol. 1991; 147:3303-3305.
    View PubMed
  268. Hetzel DJ, Stanhope CR, O'Neill BP, Lennon VA. Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume. Mayo Clin Proc. 1990 Dec; 65 (12):1558-63
    View PubMed
  269. Brimijoin S, Brimijoin S, Lennon VA. Autoimmune preganglionic sympathectomy induced by acetylcholinesterase antibodies. Proc Natl Acad Sci U S A. 1990 Dec; 87 (24):9630-4
    View PubMed
  270. Hammack JE, Kimmel DW, O'Neill BP, Lennon VA. Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies. Mayo Clin Proc. 1990 Nov; 65 (11):1423-31
    View PubMed
  271. Griesmann GE, McCormick DJ, De Aizpurua HJ, Lennon VA. Alpha-bungarotoxin binds to human acetylcholine receptor alpha-subunit peptide 185-199 in solution and solid phase but not to peptides 125-147 and 389-409. J Neurochem. 1990 May; 54 (5):1541-7
    View PubMed
  272. Bartges JW, Klausner JS, Bostwick EF, Hakala JE, Lennon VA. Clinical remission following plasmapheresis and corticosteroid treatment in a dog with acquired myasthenia gravis. J Am Vet Med Assoc. 1990 Apr 15; 196(8):1276-8.
    View PubMed
  273. Williams CL, Lennon VA. Activation of M3 muscarinic acetylcholine receptors inhibits voltage-dependent calcium influx in small cell lung carcinoma. J Biol Chem. 1990 Jan 25; 265 (3):1443-7
    View PubMed
  274. Brimijoin S, Balm M, Brimijoin S, Hammond P, Lennon VA. Selective complexing of acetylcholinesterase in brain by intravenously administered monoclonal antibody. J Neurochem. 1990 Jan; 54 (1):236-41
    View PubMed
  275. Rodriguez M, Lennon VA. Immunoglobulins promote remyelination in the central nervous system. Ann Neurol. 1990 Jan; 27(1):12-7.
    View PubMed
  276. Lennon VA, Lambert EH. Autoantibodies bind solubilized calcium channel-omega-conotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert- Eaton myasthenic syndrome. Mayo Clin Proc. 1989 Dec; 64(12):1498-504.
    View PubMed
  277. Lennon VA, Griesmann GE. Evidence against acetylcholine receptor having a main immunogenic region as target for autoantibodies in myasthenia gravis. Neurology. 1989 Aug; 39 (8):1069-76
    View PubMed
  278. Williams CL, Lennon VA, Pittelkow MR. Novel redistribution of myosin-containing filaments in cultured keratinocytes identified by a human monoclonal autoantibody. In Vitro Cell Dev Biol. 1989 May; 25 (5):397-401
    View PubMed
  279. Lambert EH, Lennon VA. Selected IgG rapidly induces Lambert-Eaton myasthenic syndrome in mice: complement independence and EMG abnormalities. Muscle & Nerve. 1988 Nov; 11(11):1133-45.
    View PubMed
  280. Rodriguez M, Truh LI, Rodriguez M, O'Neill BP, Lennon VA. Autoimmune paraneoplastic cerebellar degeneration: ultrastructural localization of antibody-binding sites in Purkinje cells. Neurology. 1988 Sep; 38 (9):1380-6
    View PubMed
  281. De Aizpurua HJ, Lambert EH, Griesmann GE, Olivera BM, Lennon VA. Antagonism of voltage-gated calcium channels in small cell carcinomas of patients with and without Lambert-Eaton myasthenic syndrome by autoantibodies omega-conotoxin and adenosine. Cancer Res. 1988 Sep 1; 48(17):4719-24.
    View PubMed
  282. Cikes N, Momoi MY, Williams CL, Howard FM Jr, Hoagland HC, Whittingham S, Lennon VA. Striational autoantibodies: quantitative detection by enzyme immunoassay in myasthenia gravis, thymoma, and recipients of D-penicillamine or allogeneic bone marrow. Mayo Clin Proc. 1988 May; 63 (5):474-81
    View PubMed
  283. Joseph RJ, Carrillo JM, Lennon VA. Myasthenia gravis in the cat. J Vet Intern Med. 1988 Apr-Jun; 2(2):75-9.
    View PubMed
  284. Smith JL, Finley JC, Lennon VA. Autoantibodies in paraneoplastic cerebellar degeneration bind to cytoplasmic antigens of Purkinje cells in humans, rats and mice and are of multiple immunoglobulin classes. J Neuroimmunol. 1988 Apr; 18 (1):37-48
    View PubMed
  285. Rodriguez M, Lucchinetti CF, Clark RJ, Yakash TL, Markowitz H, Lennon VA. Immunoglobulins and complement in demyelination induced in mice by Theiler's virus. J Immunol. 1988 Feb 1; 140(3):800-6.
    View PubMed
  286. De Aizpurua HJ, Griesmann GE, Lambert EH, Lennon VA. Voltage-dependent Ca2+ channels in small cell carcinomas are blocked by autoantibodies from patients with Lambert-Eaton myasthenic syndrome. Ann N Y Acad Sci. 1988; 540:369-71
    View PubMed
  287. Lennon VA, Huang ZX, McCormick DJ, Griesmann GE, Fujii N, Lambert EH. Synthetic peptide of human acetylcholine receptor alpha-subunit sequence 125-147 (methionine 144), a more potent autoantigen than its norleucine 144 analog. Ann N Y Acad Sci. 1988; 540:516-9
    View PubMed
  288. Kimmel DW, O'Neill BP, Lennon VA. Subacute sensory neuronopathy associated with small cell lung carcinoma: diagnosis aided by autoimmune serology. Mayo Clin Proc. 1988 Jan; 63 (1):29-32
    View PubMed
  289. McCormick DJ, Griesman GE, Huang ZX, Lambert EH, Lennon VA. Myasthenogenicity of human acetylcholine receptor synthetic a-subunit peptide 125-147 does not require intramolecular disulfide cyclization. J Immunol. 1987 Oct 15; 139:2615-2619.
    View PubMed
  290. Hitt ME, Shaw DP, Hogan PM, Lennon VA, Amann JF. Radiation treatment for thymoma in a dog. J Am Vet Med Assoc. 1987 May 1; 190(9):1187-90.
    View PubMed
  291. Rodriguez M, Lennon VA, Benveniste EN, Merrill JE. Remyelination by oligodendrocytes stimulated by antiserum to spinal cord. Journal of Neuropathology & Experimental Neurology. 1987 Jan; 46(1):84-95.
    View PubMed
  292. Williams CL, Lennon VA, Momoi MY, Howard FM Jr. Serum antibodies and monoclonal antibodies secreted by thymic B-cell clones from patients with myasthenia gravis define striational antigens. Ann N Y Acad Sci. 1987; 505:168-79
    View PubMed
  293. Pascuzzi RM, Phillips LH II, Johns TR, Lennon VA. The prevalence of electrophysiological and immunological abnormalities in asymptomatic relatives of patients with myasthenia gravis. Ann N Y Acad Sci. 1987; 505:407-15.
    View PubMed
  294. Lennon VA, Griesmann GA, McCormick DJ, Huang ZX, Feng H, Lambert EH. Definition of myasthenogenic sites of the human acetylcholine receptor using synthetic peptides. Ann N Y Acad Sci. 1987; 505:439-50
    View PubMed
  295. Howard FM Jr, Lennon VA, Finley J, Matsumoto J, Elveback LR. Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis. Ann N Y Acad Sci. 1987; 505:526-38
    View PubMed
  296. Williams CL, Lennon VA. Thymic B lymphocyte clones from patients with myasthenia gravis secrete monoclonal striational autoantibodies reacting with myosin, alpha actinin, or actin. J Exp Med. 1986 Oct 1; 164(4):1043-59.
    View PubMed
  297. Momoi MY, Lennon VA. Evidence for structural dissimilarity in the neurotransmitter binding region of purified acetylcholine receptors from human muscle and Torpedo electric organ. J Neurochem. 1986 Jan; 46(1):76-81.
    View PubMed
  298. Lennon VA, McCormick DJ, Lambert EH, Griesmann GE, Atassi MZ. Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies. Proc Natl Acad Sci U S A. 1985 Dec; 82(24):8805-9.
    View PubMed
  299. Cunningham JM, Lennon VA, Lambert EH, Scheithauer B. Acetylcholine receptors in small cell carcinomas. J Neurochem. 1985 Jul; 45(1):159-67.
    View PubMed
  300. Gorzynski TJ, Lennon VA, Nathanson RM, David CS. AKR/J gene(s) unlinked to H-2 determines dominant inheritance of lymphocyte hyporesponsiveness to acetylcholine receptor. J Immunol. 1985 Apr; 134(4):2079-83.
    View PubMed
  301. McCormick DJ, Lennon VA, Atassi MZ. Synthesis of an antigenic site of native acetylcholine receptor peptide 159-169 of Torpedo acetylcholine receptor alpha-chain. Biochem J. 1985 Feb 15; 226(1):193-7.
    View PubMed
  302. Tateishi K, Klee GG, Cunningham JM, Lennon VA. Stability of bombesin in serum, plasma, urine, and culture media. Clin Chem. 1985 Feb; 31(2):276-8.
    View PubMed
  303. Oda K, Lambert EH, Lennon VA, Palmer AC. Congenital canine myasthenia gravis: I. Deficient junctional acetylcholine receptors. Muscle & Nerve. 1984 Nov-Dec; 7(9):705-16.
    View PubMed
  304. Oda K, Lennon VA, Lambert EH, Palmer AC. Congenital canine myasthenia gravis: II. Acetylcholine receptor metabolism. Muscle & Nerve. 1984 Nov-Dec; 7(9):717-24.
    View PubMed
  305. Prineas JW, Kwon EE, Sternberger NH, Lennon VA. The distribution of myelin-associated glycoprotein and myelin basic protein in actively demyelinating multiple sclerosis lesions. J Neuroimmunol. 1984 Jul; 6(4):251-64.
    View PubMed
  306. Lang W, Rodriguez M, Lennon VA, Lampert PW. Demyelination and remyelination in murine viral encephalomyelitis. Ann N Y Acad Sci. 1984; 436:98-102.
    View PubMed
  307. Momoi MY, Lennon VA. The stability of solubilized mammalian muscle acetylcholine receptors during purification by monoclonal immunoadsorption. J Neurochem. 1984 Jan; 42(1):59-64.
    View PubMed
  308. Miller LM, Lennon VA, Lambert EH, Reed SM, Hegreberg GA, Miller JB, Ott RL. Congenital myasthenia gravis in 13 smooth fox terriers. J Am Vet Med Assoc. 1983 Apr 1; 182(7):694-7.
    View PubMed
  309. Fairbanks VF, Lennon VA, Kokmen E, Howard FM. Tests for pernicious anemia: serum intrinsic factor blocking antibody. Mayo Clin Proc. 1983 Mar; 58(3):203-4.
    View PubMed
  310. Indrieri RJ, Creighton SR, Lambert EH, Lennon VA. Myasthenia gravis in two cats. J Am Vet Med Assoc. 1983 Jan 1; 182(1):57-60.
    View PubMed
  311. Momoi MY, Lennon VA. Purification and biochemical characterization of nicotinic acetylcholine receptors of human muscle. J Biol Chem. 1982 Nov 10; 257(21):12757-64.
    View PubMed
  312. Lennon VA. Myasthenia gravis: diagnosis by assay of serum antibodies to acetylcholine receptor. Mayo Clin Proc. 1982 Nov; 57:723-724.
    View PubMed
  313. Kelly JJ, Daube JR, Lennon VA, Howard FM, Younge BR. The laboratory diagnosis of mild myasthenia gravis. Ann Neurol. 1982 Sep; 12(3):238-42.
    View PubMed
  314. Christadoss P, Lennon VA, Krco CJ, David CS. Genetic control of experimental autoimmune myasthenia gravis in mice. III. Ia molecules mediate cellular immune responsiveness to acetylcholine receptors. J Immunol. 1982 Mar; 128(3):1141-4.
    View PubMed
  315. Carter J, Lennon VA, Schreiber P, Brimijoin S. Content and release of acetylcholinesterase in skeletal muscle of rats with experimental autoimmune myasthenia gravis. Exp Neurol. 1982 Feb; 75(2):490-500.
    View PubMed
  316. Lennon VA, Lambert EH, Whittingham S, Fairbanks V. Autoimmunity in the Lambert-Eaton myasthenic syndrome. Muscle & Nerve. 1982; 5(9S):S21-5.
    View PubMed
  317. Lambert EH, Lennon VA. Neuromuscular transmission in nude mice bearing oat cell tumors from Lambert-Eaton myasthenic syndrome. Muscle & Nerve. 1982; 5(9S):S39-45.
    View PubMed
  318. Donat JF, Donat JR, Lennon VA. Exchange transfusion in neonatal myasthenia gravis. Neurology. 1981 Jul; 31(7):911-2.
    View PubMed
  319. Christadoss P, Krco CJ, Lennon VA, David CS. Genetic control of experimental autoimmune myasthenia gravis in mice. II. Lymphocyte proliferative response to acetylcholine receptor is dependent on Lyt-1+23- cells. J Immunol. 1981 Apr; 126(4):1646-7.
    View PubMed
  320. Wier ML, Lennon VA. Differentiation of skeletal muscle from dissociated optic nerve cells. Immunocytochemical observations. J Neuroimmunol. 1981 Mar; 1(1):61-8.
    View PubMed
  321. Lennon VA, Lambert EH. Monoclonal autoantibodies to acetylcholine receptors: evidence for a dominant idiotype and requirement of complement for pathogenicity. Ann N Y Acad Sci. 1981; 377:77-96.
    View PubMed
  322. Christadoss P, Lennon VA, Krco CJ, Lambert EH, David CS. Genetic control of autoimmunity to acetylcholine receptors: role of ia molecules. Ann N Y Acad Sci. 1981; 377:258-77.
    View PubMed
  323. Palmer AC, Lennon VA, Beadle C, Goodyear JV. Autoimmune form of myasthenia gravis in a juvenile Yorkshire Terrier x Jack Russell Terrier hybrid contrasted with congenital (non- autoimmune) myasthenia gravis of the Jack Russell. J Small Anim Pract. 1980 Jun; 21(6):359-64.
    View PubMed
  324. Lennon VA, Thompson M, Chen J. Properties of nicotinic acetylcholine receptors isolated by affinity chromatography on monoclonal antibodies. J Biol Chem. 1980 May 25; 255(10):4395-8.
    View PubMed
  325. Lennon VA, Lambert EH. Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors. Nature. 1980 May 22; 285(5762):238-40.
    View PubMed
  326. Lennon VA, Peterson S, Schubert D. Neurectoderm markers retained in phenotypical skeletal muscle cells arising from a glial cell line. Nature. 1979 Oct 18; 281(5732):586-8.
    View PubMed
  327. Engel AG, Sakakibara H, Sahashi K, Lindstrom JM, Lambert EH, Lennon VA. Passively transferred experimental autoimmune myasthenia gravis. Neurology. 1979; 29:179-188.
    View PubMed
  328. Christadoss P, Lennon VA, David C. Genetic-control of experimental autoimmune myasthenia-gravis in mice 1 lymphocyte proliferative response to acetylcholine-receptor is under h-2-linked IR gene-control. J Immunol. 1979; 123:2540-2543.
    View PubMed
  329. Kelly JJ, Lambert EH, Lennon VA. Acetylcholine release in diaphragm of rats with chronic experimental autoimmune myasthenia gravis. Ann Neurol. 1978 Jul; 4(1):67-72.
    View PubMed
  330. Lennon VA, Seybold ME, Lindstrom JM, Cochrane C, Ulevitch R. Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis. J Exp Med. 1978 Apr 1; 147(4):973-83.
    View PubMed
  331. Sahashi K, Engel AG, Linstrom JM, Lambert EH, Lennon VA. Ultrastructural localization of immune complexes (IgG and C3) at the end-plate in experimental autoimmune myasthenia gravis. Journal of Neuropathology & Experimental Neurology. 1978 Mar-Apr; 37(2):212-23.
    View PubMed
  332. Lennon VA, Unger M, Dulbecco R. Thy-1-differentiation marker of potential mammary myoepithelial cells in vitro. Proc Natl Acad Sci U S A. 1978; 75:6093-6097.
    View PubMed
  333. Westall FC, Lennon VA, Gospodarowicz D. Brain-derived fibroblast growth-factor-identity with a fragment of basic-protein of myelin. Proc Natl Acad Sci U S A. 1978; 75:4675-4678.
    View PubMed
  334. Lennon VA. Immunopathology of myasthenia gravis. Hum Pathol. 1978; 9:541-551.
    View PubMed
  335. Lesley JF, Lennon VA. Thy-1 antigen expression on rat-brain cell lines. Brain Res. 1978; 153:109-120.
    View PubMed
  336. Westall FC, Thompson M, Lennon VA. Hyperacute autoimmune encephalomyelitis induced by a synthetic autoantigen. Nature. 1977 Sep 29; 269(5627):425-7.
    View PubMed
  337. Hill PK, Lindstrom JM, Lennon VA, Dyck PJ. Experimental autoimmune myasthenia gravis: No morphometric abnormalities of nerve trunks. Neurology. 1977 Feb; 27(2):200-1.
    View PubMed
  338. Engel AG, Lindstrom JM, Lambert EH, Lennon VA. Ultrastructural localization of acetylcholine-receptor in myasthenia gravis and in its experimental autoimmune model. Neurology. 1977; 27:307-315.
    View PubMed
  339. Lennon VA, Westall FC, Thompson M, Ward E. Antigen, host and adjuvant requirements for induction of hyperacute experimental autoimmune encephalomyelitis. Eur J Immunol. 1976 Nov; 6(11):805-10.
    View PubMed
  340. Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology. 1976 Nov; 26(11):1054-9.
    View PubMed
  341. Engel AG, Tsujihata M, Lambert EH, Lindstrom JM, Lennon VA. Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations. Journal of Neuropathology & Experimental Neurology. 1976 Sep-Oct; 35(5):569-87.
    View PubMed
  342. Lennon VA. Immunology of acetylcholine-receptor. Immunol Commun. 1976; 5:323-344.
    View PubMed
  343. Lambert EH, Lindstrom JM, Lennon VA. End-plate potentials in experimental autoimmune myasthenia gravis in rats. Ann N Y Acad Sci. 1976; 274:300-18.
    View PubMed
  344. Lennon VA, Lindstrom JM, Seybold ME. Experimental autoimmune myasthenia gravis: cellular and humoral immune responses. Ann N Y Acad Sci. 1976; 274:283-99.
    View PubMed
  345. Seybold ME, Lambert EH, Lennon VA, Lindstrom JM. Experimental autoimmune myasthenia: clinical, neurophysiologic, and pharmacologic aspects. Ann N Y Acad Sci. 1976; 274:275-82.
    View PubMed
  346. Lindstrom JM, Lennon VA, Seybold ME, Whittingham S. Experimental autoimmune myasthenia gravis and myasthenia gravis: biochemical and immunochemical aspects. Ann N Y Acad Sci. 1976; 274:254-74.
    View PubMed
  347. Lindstrom JM, Einarson BL, Lennon VA, Seybold ME. Pathological mechanisms in experimental autoimmune myasthenia gravis. 1. Immunogenicity of syngeneic muscle acetylcholine-receptor, and quantitative extraction of receptor, and antibody-receptor complexes from muscles of rats with experimental autoimmune myasthenia gravis. J Exp Med. 1976; 144:726-738.
    View PubMed
  348. Engel AG, Tsujihata M, Lindstrom MJ, Lennon VA. Motor end plate in myasthenia gravis and in experimental autoimmune myasthenia-gravis - quantitative ultrastructural-study. Ann N Y Acad Sci. 1976; 274:60-79.
    View PubMed
  349. Bevan S, Heinemann S, Lennon VA, Lindstrom J. Reduced muscle acetylcholine sensitivity in rats immunized with acetylcholine-receptor. Nature. 1976; 260:438-439.
    View PubMed
  350. Lindstrom JM, Engel AG, Seybold ME, Lennon VA, Lambert EH. Pathological mechanisms in experimental autoimmune myasthenia gravis 2. passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine receptor antibodies. J Exp Med. 1976; 144:739-753.
    View PubMed
  351. Crain SM, Bornstein B, Bornstein MB, Lennon VA. Depression of complex bioelectric discharges in cerebral tissue cultures by thermolabile complement-dependent serum factors. Exp Neurol. 1975; 49:330-335.
    View PubMed
  352. Lennon VA, Lindstrom JM, Seybold ME. Experimental autoimmune myasthenia-model of myasthenia gravis in rats and guinea pigs. J Exp Med. 1975; 141:1365-1375.
    View PubMed
  353. Shier WT, Trotter JT 3rd, Reading CL, Lennon VA. Adjuvant activity for alkylamines of immune responses to ovalbumin, myelin basic protein and a tumor. International Archives of Allergy & Applied Immunology. 1974; 47(5):688-95.
    View PubMed
  354. Lennon VA, Dunkley PR. Humoral and cell-mediated immune responses of Lewis rats to syngeneic basic protein of myelin. International Archives of Allergy & Applied Immunology. 1974; 47(4):598-608.
    View PubMed
  355. Lennon VA, Carnegie PR. Immunological responses of guinea pigs to a synthetic autoantigen of brain. Eur J Immunol. 1974 Jan; 4(1):60-2.
    View PubMed
  356. Lennon VA, Byrd WJ. Letter: Experimental arthritis in thymectomized rats with an impaired humoral immune response. Nature. 1973 Jul 6; 244(5410):38-40.
    View PubMed
  357. Lennon VA, Byrd WJ. Role of T lymphocytes in the pathogenesis of experimental autoimmune encephalomyelitis. Eur J Immunol. 1973 Apr; 3(4):243-5.
    View PubMed
  358. Coates AS, Lennon VA. Lymphocytes binding basic protein of myelin; cytophilic serum antibody and effect of adjuvant. Immunology. 1973 Mar; 24(3):425-34.
    View PubMed
  359. Lennon V, Mackay IR. Binding of 125 I myelin basic protein by serum and cerebrospinal fluid. Clinical & Experimental Immunology. 1972 Aug; 11(4):595-603.
    View PubMed
  360. Lennon V, Feldmann M, Crawford M. The detection of autoantibody-forming cells. II. Cells in lymph nodes and central nervous system containing antibody to myelin basic protein. International Archives of Allergy & Applied Immunology. 1972; 43(5):749-58.
    View PubMed
  361. Lennon V, Feldmann M. The detection of autoantibody-forming cells. I. An assay for plaque-forming cells to the basic protein of myelin in guinea-pigs. International Archives of Allergy & Applied Immunology. 1972; 42(4):627-40.
    View PubMed
  362. Lennon VA, Whittingham S, Carnegie PR, McPherson TA, Mackay IR. Detection of antibodies to the basic protein of human myelin by radioimmunoassay and immunofluorescence. J Immunol. 1971 Jul; 107(1):56-62.
    View PubMed
  363. Lennon VA, Carnegie PR. Immunopharmacological disease: a break in tolerance to receptor sites. Lancet. 1971 Mar 27; 1(7700):630-3.
    View PubMed
  364. McPherson TA, Marchalonis JJ, Lennon V. Binding of encephalitogenic basic protein by serum alpha-globulins. Immunology. 1970 Dec; 19(6):929-33.
    View PubMed
  365. Lennon VA, Wilks AV, Carnegie PR. Immunologic properties of the main encephalitogenic peptide from the basic protein of human myelin. J Immunol. 1970 Nov; 105(5):1223-30.
    View PubMed
  366. Morris JG, Smitananda N, Lennon V. Liver and spleen scanning as a diagnostic aid. Med J Aust. 1966 Dec 10; 2(24):1160-6.
    View PubMed
PST-20219633